These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 15028614)

  • 21. Initial evaluation of novel selective ligands for imidazoline(2) receptors in rat whole brain.
    Tyacke RJ; Sazczewski F; Tabin P; Sazczewski J; Nutt DJ; Hudson AL
    Ann N Y Acad Sci; 2003 Dec; 1009():357-60. PubMed ID: 15028611
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic administration of 2-(2-benzofuranyl)-2-imidazoline (2-BFI) induces region-specific increases in [3H]2-BFI binding to rat central imidazoline I2 sites.
    MacInnes N; Handley SL
    Neurosci Lett; 2004 Jun; 363(1):11-3. PubMed ID: 15157985
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship between I2 imidazoline binding sites and monoamine oxidase B in liver.
    Remaury A; Ordener C; Shih J; Parini A
    Ann N Y Acad Sci; 1999 Jun; 881():32-4. PubMed ID: 10415894
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of an I(2) binding protein from rabbit brain.
    Kimura A; Tyacke RJ; Minchin MC; Nutt DJ; Hudson AL
    Ann N Y Acad Sci; 2003 Dec; 1009():364-6. PubMed ID: 15028613
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural and ligand recognition properties of imidazoline binding proteins in tissues of rat and rabbit.
    Lanier B; Raddatz R; Bakthavachalam V; Coupry I; Neumeyer JL; Lanier SM
    Mol Pharmacol; 1995 Oct; 48(4):703-10. PubMed ID: 7476897
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Down-regulation of MAO-B activity and imidazoline receptors in rat brain following chronic treatment of morphine.
    Su RB; Li J; Li X; Qin BY
    Acta Pharmacol Sin; 2001 Jul; 22(7):639-44. PubMed ID: 11749830
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Imidazoline binding domains on MAO-B. Localization and accessibility.
    Raddatz R; Savic SL; Lanier SM
    Ann N Y Acad Sci; 1999 Jun; 881():26-31. PubMed ID: 10415893
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of monoamine oxidase A and B activities by imidazol(ine)/guanidine drugs, nature of the interaction and distinction from I2-imidazoline receptors in rat liver.
    Ozaita A; Olmos G; Boronat MA; Lizcano JM; Unzeta M; García-Sevilla JA
    Br J Pharmacol; 1997 Jul; 121(5):901-12. PubMed ID: 9222546
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Densities of I2-imidazoline receptors, imidazoline receptor proteins, and MAO-B sites in human gliomas and pituitary adenomas.
    Barturen F; Ventayol P; Ozaita A; Escribá PV; Meana JJ; García-Sevilla JA
    Ann N Y Acad Sci; 1999 Jun; 881():203-7. PubMed ID: 10415917
    [No Abstract]   [Full Text] [Related]  

  • 30. On the formation and nature of the imidazoline I2 binding site on human monoamine oxidase-B.
    McDonald GR; Olivieri A; Ramsay RR; Holt A
    Pharmacol Res; 2010 Dec; 62(6):475-88. PubMed ID: 20832472
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between I(2) binding sites and monoamine oxidase-B activity in platelets.
    Zhu H; Piletz JE
    Ann N Y Acad Sci; 2003 Dec; 1009():347-52. PubMed ID: 15028609
    [TBL] [Abstract][Full Text] [Related]  

  • 32. I2-imidazoline binding sites: relationship with different monoamine oxidase domains and identification of histidine residues mediating ligand binding regulation by H+1.
    Limon-Boulez I; Tesson F; Gargalidis-Moudanos C; Parini A
    J Pharmacol Exp Ther; 1996 Feb; 276(2):359-64. PubMed ID: 8632297
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of I
    Keller B; García-Sevilla JA
    Neurochem Int; 2017 Sep; 108():169-176. PubMed ID: 28342965
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of amine oxidase activity by derivatives that recognize imidazoline I2 sites.
    Carpéné C; Collon P; Remaury A; Cordi A; Hudson A; Nutt D; Lafontan M
    J Pharmacol Exp Ther; 1995 Feb; 272(2):681-8. PubMed ID: 7853182
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predominant expression of monoamine oxidase B isoform in rabbit renal proximal tubule: regulation by I2 imidazoline ligands in intact cells.
    Gargalidis-Moudanos C; Remaury A; Pizzinat N; Parini A
    Mol Pharmacol; 1997 Apr; 51(4):637-43. PubMed ID: 9106629
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Localization of the imidazoline binding domain on monoamine oxidase B.
    Raddatz R; Parini A; Lanier SM
    Mol Pharmacol; 1997 Oct; 52(4):549-53. PubMed ID: 9380016
    [TBL] [Abstract][Full Text] [Related]  

  • 37. BU98008, a highly selective imidazoline(1)-receptor ligand.
    Robinson ES; Price RE; Nutt DJ; Hudson AL
    Ann N Y Acad Sci; 2003 Dec; 1009():283-7. PubMed ID: 15028601
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel ligands for the investigation of imidazoline receptors and their binding proteins.
    Hudson AL; Tyacke RJ; Lalies MD; Davies N; Finn DP; Marti O; Robinson E; Husbands S; Minchin MC; Kimura A; Nutt DJ
    Ann N Y Acad Sci; 2003 Dec; 1009():302-8. PubMed ID: 15028604
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The imidazoline I2-site ligands BU 224 and 2-BFI inhibit MAO-A and MAO-B activities, hydrogen peroxide production, and lipolysis in rodent and human adipocytes.
    Bour S; Iglesias-Osma MC; Marti L; Duro P; Garcia-Barrado MJ; Pastor MF; Prévot D; Visentin V; Valet P; Moratinos J; Carpéné C
    Eur J Pharmacol; 2006 Dec; 552(1-3):20-30. PubMed ID: 17056035
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulation of MAO activity by imidazoline and guanidine derivatives.
    Raasch W; Muhle H; Dominiak P
    Ann N Y Acad Sci; 1999 Jun; 881():313-31. PubMed ID: 10415932
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.